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H epatitis B virus (HBV) infection affects more than 350 million people worldwide and is the 
leading cause of cirrhosis and hepatocellular carcinoma 
[1].  HBV surface antigen (HBsAg) vaccination pro-
grams have been carried out in many countries since 
the 1980s and have been highly effective in decreasing 
the number of new HBV infections [2].  The protective 
effect of such a vaccination is dependent mainly on the 
induction of a specific antibody response.  However,  
approx.  5-10% of healthy adults fail to develop anti-HBs 
antibodies after a standard course of vaccination [3].
A twin vaccination study revealed that > 60% of the 
observed variability in immune responses can be 
explained by genetic factors [4].  That study’s authors 
also suggested that approx.  40% of the genetic contri-
bution is determined by human leukocyte antigen 
(HLA) genes,  with the DRB1＊ locus estimated to 
account for 0.25 and the remaining heritability of 0.36 
being assigned to other gene loci [4].  Several case con-
trol studies have compared the frequencies of HLA class 
II antigens among HBsAg responders and non-re-
sponders,  revealing both alleles strongly associated 
with a high response [DRB1＊01 (DR1),  DRB1＊11 
(DR5),  DRB1＊15 (DR2),  DQB1＊0501,  and DPB1 
＊0401] and alleles strongly associated with a poor 
response/non-responsiveness [DRB1＊03,  DRB1＊07,  
DQB1＊02,  and DPB1＊1101] [5-7].  However,  these 
alleles tend to have a low frequency in the Japanese 
population.
HLA class II molecules mediate the activation of 
helper T (Th) cells by antigen binding.  Several groups 
have suggested that antibody non-responders to vacci-
nation fail to show HBsAg-specific Th cell activation in 
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vitro [8].  Most of the genes involved in the regulation of 
responsiveness to HBsAg are still unknown,  particu-
larly with regard to the influence of ethnicity and geo-
graphic location.  Little is known about the HLA types 
related to the induction of immunity by HBsAg vacci-
nation in the Japanese population,  although an associ-
ation has been demonstrated between HLA haplotypes 
and response/non-response to HBsAg [9 , 10].  It has 
also been suggested that age-associated changes of 
humoral immunity may result in decreased effective-
ness of vaccinations [11].
We designed the present study to examine two poly-
morphisms of HLA class II alleles (HLA-DRB1＊ and 
HLA-DQB1＊) in a genetically homogenous population 
of Japanese university students,  in order to avoid the 
influence of host-related factors (such as age,  gender,  
obesity,  chronic disease and immunodeficiency),  by 
comparing good responders and poor responders par-
ticipating in the same HBsAg vaccination program.
Subjects and Methods
The subjects were selected in order to minimize the 
influence of age and to allow the elucidation of genetic 
factors influencing the response to HBsAg vaccine in a 
Japanese population.  The subjects were 123 volunteers 
who were healthy,  non-obese,  non-smoking,  fourth-
year students from the Laboratory of Science,  Saitama 
Prefectural University School of Health and the 
Department of Medical Technology,  Kagawa Prefectural 
University of Health Sciences (26 men and 97 women 
aged 21-24 years; body mass index < 25.0 kg/m2).  This 
study was approved by the Ethics Committees of 
Saitama Prefectural University and Kagawa Prefectural 
University of Health Sciences.  The objectives of the 
study were explained to all of the subjects,  and written 
consent was obtained in accord with the Declaration of 
Helsinki.
The primary objective of the HBsAg vaccination 
program was to prepare the subjects for clinical practice.  
They received the first,  second,  and third doses of a 
yeast-derived recombinant HBsAg vaccine (Bimmugen;  
The Chemo-Sero-Therapeutic Research Institute,  
Kumamoto,  Japan) in May,  June,  and November of 
their third year in university.  Blood samples for the 
evaluation of the anti-HBs antibody titer were collected 
in May of the subjects’ fourth year in university,  
approx.  6 months after the third dose of the vaccine.
Blood samples were drawn into blood collection 
tubes with EDTA-2Na,  plasma was separated by cen-
trifugation,  and the plasma level of HBs antibody was 
quantified by a chemiluminescence enzyme immunoas-
say (CLEIA,  Lumipulse presto II; Fuji Rebio,  Tokyo,  
Japan).  When the antibody level reached 1,000 mIU/
ml or higher,  the sample was determined by using an 
enzyme-linked immunosorbent assay (ELISA; Siemens 
Healthcare Japan,  Tokyo,  Japan).  Genomic DNA was 
extracted from buffy coat white blood cells with a DNA 
extraction kit (QIAamp DNA Blood mini kit; Qiagen,  
Hilden,  Germany) and was subjected to a sequence- 
specific primers-polymerase chain reaction (SSP-PCR) 
to amplify the HLA-DRB1 or HLA-DQB1 loci for 
“low-resolution to their two-to four-digit specificities” 
typing using synthetic oligonucleotide primers,  as 
described [12 , 13].  With reference to the known fre-
quencies in the Japanese population (jshi. umin. ac. Jp/
databank/index. html),  the target HLA-DRB1 alleles 
were ＊0101,  ＊0401-0410,  ＊0801,  ＊0901,  ＊1101,  and 
＊1501-1502,  and the HLA-DQB1 alleles were ＊0301,  
＊0302-0303,  ＊0401,  ＊0402,  and ＊0601.
Based on the anti-HBs antibody level,  we divided 
the subjects into low-responder ( < 10 mIU/ml),  mid-
dle-responder (10-100 mIU/ml),  and high-responder 
( > 100 mIU/ml) groups,  and we compared the HLA 
types of these groups.  The independence of the fre-
quencies of HLA types and each anti-HBs antibody 
group was analyzed by Fisher’s exact test.  We per-
formed a multiple regression analysis to confirm the 
influence of the individual factors on anti-HBs antibody 
production.  StatFlex ver.  6 software (ArTec,  Osaka,  
Japan) was used for all statistical analyses and p-values 
< 0.05 were considered significant.
Results
In the primary analysis,  to estimate the frequency of 
low responders to HBsAg vaccine in the Japanese popu-
lation,  we analyzed the anti-HBs antibody level in 84 
subjects given three separate programed recombinant 
HBsAg vaccines at Saitama Prefectural University.  These 
were divided into the nine low responders ( < 10 mIU/
ml,  10.7%) and the 75 responders ( ≥ 10 mIU/ml,  
89.3%).  Several case control studies have compared the 
frequencies of HLA class II antigens among HBsAg 
responders and low responders,  revealing various strong 
associations [5-8].
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To identify HLA class II alleles associated with the 
response to anti-HBs vaccine,  we performed a DNA 
analysis of HLA-DRB1 and HLA-DQB1 types in another 
39 subjects (17 low responders and 22 responders) for a 
total of 123 subjects.  Table 1 shows the frequency of 
HLA class II types in the 3 groups (low-responder,  
<10 mIU/ml; middle-responder,  10-100 mIU/ml; and 
high-responder; > 100 mIU/ml).  At the HLA-DRB1 
locus,  HLA-DRB1＊0401-0410 was positively associated 
with low mean anti-HBs antibody levels (n = 123,  mean 
± standard error [SE] 252.3 ± 82.4 vs. 674.4 ± 151.7 
mIU/ml,  positive vs. negative,  p < 0.05).  At the HLA-
DQB1 locus,  HLA-DQB1＊0301 was positively associ-
ated with low mean anti-HBs antibody levels (n = 117,  
mean ± SE; 340.2 ± 125.7 vs. 540.4 ± 118.1 mIU/ml,  
positive vs. negative,  p > 0.05).  There were significant 
differences in the frequency of DRB1＊0401-0410 and 
DQB1＊0301 by Fisher's exact test (p < 0.05 and p < 0.01 
respectively),  but there were no significant differences 
in the other HLA class II types (HLA-DRB1＊0301,  
＊0901, ＊1501-1502,  HLA-DQB1＊0302; 0303,  ＊0401;  
0402,  ＊0601,  ＊0602).
The multiple regression analysis confirmed the 
influence of HLA-DRB1＊0401-0410 and HLA-DQB1 
＊0301 on the anti-HBs antibody level (p < 0.05).  Fig. 1 
shows the anti-HBs antibody levels in relation to the 
HLA-DR and HLA-DQ types.  In particular,  the 
high-responder group dominated the combination of 
being HLA-DRB1＊0401-0410-negative and DQB1 
＊0301-positive (p < 0.05).  In addition,  there was a sig-
nificant difference between the low-responder and 
high-responder groups according to a multiple cluster 
analysis by Dunn’s method (p < 0.01).
Discussion
HBsAg vaccine is an exogenous antigen.  It is well 
documented that type differences of HLA class II mole-
cules influence the helper T-cell recognition of exoge-
nous antigens,  as well as the generation of antibodies by 
B cells [14].  HLA class II genes have very high levels of 
polymorphism,  especially the beta 1 chain.  The previ-
ous studies investigated mainly the response to HBsAg 
vaccine in western subjects,  with HLA-DRB1＊0301,  
＊0701 and HLA-DQB1＊0201 being consistently con-
firmed to be associated with non-responsiveness to 
vaccination [5-7].  However,  the frequency of these 
HLA-DR and HLA-DQ types is very low in the Japanese 
population.  In the present study we therefore focused 
on the relation between HLA-DRB1 and HLA-DQB1 
types and the response to an HBsAg vaccination in 
Japanese subjects.  Our analyses revealed that an 
increased likelihood of a low response to HBsAg vacci-
nation was significantly associated with the HLA-DRB1
＊0401-0410 and HLA-DQB1 
＊0301 alleles in young Japanese 
adults.  On the other hand,  a 
particular HLA class II type 
was not associated with a high 
antibody response to vaccina-
tion.
Our multiple regression 
analysis indicated that the 
HLA-DRB1＊0401-0410 and 
HLA-DQB1＊0301 alleles 
influenced the anti-HBs anti-
body production after vacci-
nation.  This combination of 
HLA-DR and HLA-DQ types 
may modify the conformation 
of the peptide-binding groove 
and thus influence antigen 
presentation,  resulting in 
weak responsiveness to the 
HBsAg vaccine in a segment of 
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Table 1　 HLA class II frequencies of the vaccinated subjects in each anti-HBs titer group
HBsAb (mlU/mL) Low-responder
<10.0
Middle-responder
10-100
High-responder
>100 P value
HLA-DRB1＊0101 Neg.Pos.
21
5
29
8
44
16 0.756
HLA-DRB1＊0401-0410 Neg.Pos.
9
17
19
18
38
22 0.046
HLA-DRB1＊0801 Neg.Pos.
12
4
26
5
45
10 0.737
HLA-DRB1＊0901 Neg.Pos.
10
5
26
5
43
12 0.422
HLA-DRB1＊1101 Neg.Pos.
16
1
30
4
48
8 0.788
HLA-DRB1＊1501-1502 Neg.Pos.
16
1
25
9
41
15 0.189
HLA-DQB1＊0301 Neg.Pos.
16
10
20
17
50
10 0.005
HLA-DQB1＊0302-0303 Neg.Pos.
17
7
27
7
40
19 0.506
HLA-DQB1＊0401 Neg.Pos.
12
3
26
5
52
3 0.093
HLA-DQB1＊0402 Neg.Pos.
9
6
26
5
41
14 0.227
HLA-DQB1＊0601 Neg.Pos.
10
6
16
15
33
20 0.597
Numerical values are the numbers of people.  Neg.,  negative; Pos.,  positive.  Diﬀerences in the frequency of each 
DRB1 and DQB1 type were determined by Fisher's exact test.  Signiﬁcant associations are shown in bold.
the Japanese population.  Interestingly,  the combina-
tion of HLA-DRB1＊0401-0410 negativity and HLA-
DQB1＊0301 positivity was most effective and seems to 
be an important combination of HLA class II molecules 
(HLA class II haplotype).
Our results are not in agreement with reports on 
vaccinated HBsAg antibody non-responders in western 
countries [5-7].  In the Japanese,  there is a reason why 
the HLA molecule conformation that influences an 
affinity with HBsAg will be decided by combinations of 
the different HLA-DR,  -DQ,  and -DP types with west-
ern populations.  In an earlier study we investigated the 
association between cytokine gene polymorphisms and 
the immune response to HBsAg vaccination,  and the 
results revealed that single nucleotide polymorphisms 
(SNPs) of the TNF-α and IL-10 genes may lead to ethnic 
differences in the response of Japanese individuals to 
HBsAg vaccine [15].  HLA gene polymorphisms are 
extremely common,  and the same observation applies 
to HLA class II gene polymorphisms in the Japanese 
population.  A recent genome-wide association study 
(GWAS) showed that SNPs in the HLA-DR region are 
associated with the response to HBsAg vaccine [16],  
and thus it may be important to study responsible SNPs 
rather than assessing the influence of HLA types.  It was 
indicated that the HLA class II region has the key influ-
ence on antibody titers after HBsAg vaccination [14].  
Although we did not do so in the present study,  it 
appears to be necessary to investigate HLA-DP alleles in 
the future.  Further well-designed analyses of the 
Japanese population and other ethnicities are required 
to confirm our findings,  toward the development of 
more effective hepatitis B vaccine.  It may also be help-
ful to design more effective vaccination methods by 
using a pre-inoculation test to check the influencing 
factors such as the HLA types and polymorphisms of 
cytokine genes.
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Fig. 1　 The multiple regression analysis results.  The distribution 
of the low-,  middle- and high-responder groups is shown for each 
HLA-DRB1＊04 and HLA-DQB1＊03 type.
The numbers of subjects are shown in parentheses (n=117 total).
